Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Alzheimer's disease-related mutations in APP influence colorectal tumor formation in a sex-dependent manner.

Created on 12 Jul 2026

Authors

Takako Ishida-Takaku, Mona Sohrabi, Heidi L Pecoraro, Colin K Combs

Published in

iScience. Volume 29. Issue 7. Pages 116645. Jul 17, 2026. Epub Jul 02, 2026.

Abstract

Cancer and Alzheimer's disease (AD) are age-associated diseases. Studies have indicated common mechanisms and interactions between these conditions. Epidemiological data demonstrate negative correlations between several cancers and AD. Despite this, few studies have explored their mutual influence on pathological outcomes. We utilized a human amyloid precursor protein (APP) mutant knock-in AD mouse model to investigate how familial mutations influence colorectal cancer development. Using a colitis-associated colorectal cancer (CAC) model, APP mutations promoted colon tumor formation in male mice but inhibited it in female mice. Correspondingly, inflammatory changes were reduced in the colons of female mice. Transcriptome analysis revealed differential expression, particularly in the enrichment of neuronal marker, steroid hormone, and immune cell signaling pathways. Additionally, distinct macrophage subtypes and neuronal profiles were observed in the colons of male and female APP mutant mice. These findings provide the first elucidation of the sex-dependent effects of APP mutations on colon cancer formation.

PMID:
42436978
Bibliographic data and abstract were imported from PubMed on 12 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement